Invesco Ltd. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$12,151,519
-26.2%
757,576
+6.7%
0.00%
-25.0%
Q2 2023$16,456,780
+67.4%
709,956
+67.8%
0.00%
+33.3%
Q1 2023$9,830,262
-16.1%
423,171
-47.6%
0.00%0.0%
Q4 2022$11,720,321
+43.0%
807,741
+88.0%
0.00%0.0%
Q3 2022$8,196,000
+1.8%
429,607
-3.0%
0.00%
+50.0%
Q2 2022$8,049,000
-51.6%
442,985
-32.9%
0.00%
-50.0%
Q1 2022$16,626,000
-23.8%
659,792
-16.6%
0.00%
-20.0%
Q4 2021$21,825,000
-16.2%
790,752
-1.9%
0.01%
-28.6%
Q3 2021$26,032,000
+11.1%
806,225
+5.3%
0.01%
+16.7%
Q2 2021$23,422,000
-21.6%
765,898
-22.0%
0.01%
-25.0%
Q1 2021$29,881,000
+200.6%
981,301
+95.2%
0.01%
+166.7%
Q4 2020$9,941,000
+52.2%
502,710
+0.4%
0.00%
+50.0%
Q3 2020$6,530,000
-39.7%
500,818
-47.5%
0.00%
-50.0%
Q2 2020$10,827,000
-12.5%
954,779
+10.5%
0.00%
-20.0%
Q1 2020$12,367,000
-9.0%
864,172
+73.2%
0.01%
+25.0%
Q4 2019$13,583,000
-73.3%
498,807
-71.9%
0.00%
-69.2%
Q3 2019$50,886,000
-1.3%
1,777,347
-4.2%
0.01%0.0%
Q2 2019$51,563,000
+0.1%
1,856,133
+19.7%
0.01%
-23.5%
Q1 2019$51,493,000
+7.7%
1,550,990
-5.7%
0.02%
-5.6%
Q4 2018$47,800,000
-27.4%
1,644,337
+14.9%
0.02%
-14.3%
Q3 2018$65,802,000
+71.7%
1,430,487
+39.5%
0.02%
+61.5%
Q2 2018$38,320,000
+60.9%
1,025,430
+27.3%
0.01%
+44.4%
Q1 2018$23,811,000
-0.4%
805,820
+15.8%
0.01%0.0%
Q4 2017$23,902,000
+34.6%
695,938
+41.8%
0.01%
+28.6%
Q3 2017$17,753,000
+19.2%
490,692
-14.9%
0.01%
+40.0%
Q2 2017$14,892,000
+25.5%
576,317
-6.7%
0.01%
+25.0%
Q1 2017$11,862,000
+54.6%
617,827
+34.2%
0.00%
+33.3%
Q4 2016$7,673,000
-8.5%
460,316
+13.0%
0.00%0.0%
Q3 2016$8,387,000
-77.9%
407,500
-67.2%
0.00%
-78.6%
Q2 2016$37,994,000
-33.0%
1,241,580
-18.1%
0.01%
-39.1%
Q1 2016$56,731,000
+19.7%
1,515,638
+38.0%
0.02%
+21.1%
Q4 2015$47,399,000
+56.9%
1,098,189
+36.3%
0.02%
+46.2%
Q3 2015$30,209,000
+50.4%
805,986
+36.4%
0.01%
+62.5%
Q2 2015$20,091,000
-9.3%
591,071
-5.5%
0.01%
-11.1%
Q1 2015$22,139,000
-15.3%
625,383
-18.5%
0.01%
-10.0%
Q4 2014$26,123,000
-33.3%
766,943
-24.4%
0.01%
-37.5%
Q3 2014$39,142,000
-16.4%
1,014,845
-15.7%
0.02%
-11.1%
Q2 2014$46,828,000
+14.6%
1,203,172
+0.7%
0.02%
+5.9%
Q1 2014$40,866,000
+104.4%
1,195,271
+25.4%
0.02%
+112.5%
Q4 2013$19,989,000
+14.0%
952,821
+27.7%
0.01%0.0%
Q3 2013$17,535,000
+34.2%
746,205
+53.4%
0.01%
+33.3%
Q2 2013$13,067,000486,3380.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders